Cirrhosis is one of the leading causes of mortality from non-communicable diseases, with complications arising as liver function deteriorates.
Bluebird’s slow sickle cell launch forces rework of loan, putting cash runway at risk
Bluebird bio reported Wednesday that just four patients have started the process for receiving its sickle cell therapy Lyfgenia, endangering a $50 million loan that